At NINGBO INNO PHARMCHEM CO.,LTD., we are passionate about the science that underpins effective pharmaceutical solutions. Brimonidine D-Tartrate, a core product in our portfolio, is central to advancements in ocular pressure management. Understanding its pharmacological mechanism is crucial for appreciating its value in treating conditions like glaucoma and ocular hypertension.

Brimonidine D-Tartrate, known by its CAS number 70359-46-5, functions as a selective alpha-2 adrenergic receptor agonist. Its primary therapeutic effect is to reduce intraocular pressure (IOP). This is achieved through two main pathways: it decreases the production of aqueous humor, the fluid that fills the front part of the eye, and it also enhances the uveoscleral outflow of this humor. This dual action makes it a highly effective agent for patients experiencing elevated IOP.

When manufacturers buy Brimonidine D-Tartrate raw material, they are sourcing an API that has a well-defined mechanism of action, contributing to predictable therapeutic outcomes. As a dedicated brimonidine d-tartrate supplier, NINGBO INNO PHARMCHEM CO.,LTD. ensures that the compound's biological activity is preserved through meticulous quality control. The physical form, a fine white to off-white powder, is optimized for formulation processes, making it an ideal ophthalmic solution active ingredient.

The development of brimonidine d-tartrate for glaucoma treatments relies heavily on the precise pharmacological properties of the API. Similarly, for ocular hypertension, the consistent ability of Brimonidine D-Tartrate to regulate IOP is vital. NINGBO INNO PHARMCHEM CO.,LTD. is committed to providing high purity Brimonidine D-Tartrate that not only meets chemical specifications but also upholds the necessary pharmacological characteristics for effective drug products.

Our role as a leading brimonidine d-tartrate supplier extends beyond mere provision; we aim to be partners in scientific advancement. By understanding the intricacies of brimonidine d-tartrate CAS 70359-46-5, from its chemical synthesis to its pharmacological impact, NINGBO INNO PHARMCHEM CO.,LTD. supports the innovation that drives better patient care in ophthalmology. Trust us for your supply of this scientifically significant pharmaceutical ingredient.